Search

everythinglearnresearchcommunity

for

Search:↓

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Topical minoxidil improves life quality for women with hair loss.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Cinainu is effective and safe for treating children's alopecia areata.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Bexarotene gel shows promise as a new treatment for alopecia areata.

A boy with long QT syndrome was treated successfully, highlighting the need for careful evaluation of chest pain in children for heart conditions like LQTS.

Prostaglandin analogue may help with eyebrow loss in frontal fibrosing alopecia.

Emulgels are effective for delivering skin medications and cosmetics due to their easy application and controlled release.

Ixekizumab has known and some unexpected side effects.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

The emulgel formulation F6 released more Minoxidil than the gel formulation F1.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ebastine may help regrow hair in alopecia areata patients.

The treatment was not recommended due to limited effectiveness and significant side effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Ritlecitinib is safe and may effectively treat alopecia areata.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

AMP-303 safely increases hair growth in men with hair loss.